This national clinical trial for children with acute lymphoblastic leukaemia builds on the success of the previous trial, UKALL 2003, which pioneered a new molecular technique to stratify children into different treatment groups according to residual levels of leukaemic cells. This new UKALL trial will use the technique to monitor the effect of changes to the treatment regime in an attempt to save even more children.
The genetics of familial leukaemia
Dr Pamela Kearns
University of Birmingham
Birmingham, B15 2TT
1 April 2012